Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Pharmaceutical Pricing and Reimbursement in Japan' returned 255 results - Page 1 of 13   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Pharmaceutical Pricing and Reimbursement in Japan, 2008   Decision Resources, Inc., May 2008, Pages: 39 Pharmaceutical Pricing and Reimbursement in Japan, 2008 Introduction The pharmaceutical industry faces challenging times in the Japanese market. The government has expressed its desire to reward the Pharmaceutical Pricing Strategies: Price optimization, reimbursement and regulation in Europe, US and Japan   Business Insights, April 2005, Pages: 240 Pharmaceutical Pricing Strategies: Price optimization, reimbursement and regulation in Europe, US and Japan Maximizing prices and securing reimbursement status for a product is increasing in Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure   GBI Research, March 2012, Pages: 57 Private Healthcare System 3.4 Rationale for Drug Use in the Healthcare Facilities 4 Pricing and Reimbursement in India- Overview of Pharmaceutical Regulations in India 4.1 PEST Analysis of the IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Japan   IMS Health, Sep 2011, Pages: 43 IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Japan The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies   GBI Research, Nov 2011, Pages: 68 Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies GBI Research Pharma Pricing and Reimbursement Outlook: Optimizing Price and Market Access in a Recessionary Climate   Business Insights, Nov 2009, Pages: 145 , Japan, EU5) - Establish new market opportunities for new and existing drugs based on a detailed review of pricing and reimbursement trends in the four major high growth pharmaceutical markets (Brazil Pharmaceutical Pricing and Reimbursement - Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies   GBI Research, Feb 2010, Pages: 83 particular geography in future Pharmaceutical Pricing and Reimbursement – Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies Description “Pharmaceutical IMS Pharmaceutical Pharma Pricing & Reimbursement Concise Guide Series Selected Asia-Pacific Countries & Australasia   IMS Health, Dec 2007, Pages: 126 definitive reference and training text for Pricing & Reimbursement professionals around the world. This best-selling report provides up-to-date coverage of key developments in Pricing & Reimbursement, market IMS Pharmaceutical Pharmaceutical Pricing and Reimbursement: A Concise Guide 2007   IMS Health, Jan 2007, Pages: 380 IMS Pharmaceutical Pharmaceutical Pricing and Reimbursement: A Concise Guide 2007 The definitive guide to P&R in the Pharmaceutical industry This concise guide to Pharmaceutical Pricing The Pricing and Reimbursement Environment for Respiratory Disease Therapies   Decision Resources, Inc., Oct 2011 - Pharmaceutical Pricing and Reimbursement - Cost Containment Asthma COPD Allergies Japan General Environment - Health Insurance - Pharmaceutical Reimbursement - Cost Containment Asthma COPD Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics   Decision Resources, Inc., Aug 2011 arthritis, systemic lupus erythematosus (SLE), and ulcerative colitis in seven leading pharmaceutical markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) will grow from 19 Market Access Korea - Breaking into the Developed World’s Fastest Growing Pharmaceutical Market   Just Pharma Reports, Nov 2010, Pages: 66 for lack of transparency in reimbursement decisions and unfair business practices, with the Free Trade Agreements signed with the US and the EU cementing the internationalisation process. With pricing Cancer Therapies Face Increasing Reimbursement Pressures in Europe and Japan   Decision Resources, Inc., Nov 2006, Pages: 52 Drugs . 41 Accelerated NICE Appraisal Process 41 Off-Label Prescribing 43 Japan 43 Pharmaceutical Pricing and Reimbursement 43 Prospective Payment 44 Unavailability of Gold-Standard Therapies 45 Off Pharmaceutical Pricing, Reimbursement, and Market Access News in the First Quarter of 2011   Decision Resources, Inc., May 2011 Pharmaceutical Pricing, Reimbursement, and Market Access News in the First Quarter of 2011 For the international pharmaceutical industry, 2011 began as 2010 ended, with governments in the United Pharmaceutical Pricing and Reimbursement: Strategies for Market Access Across the US, Europe, Japan and Other Key Geographies   Business Insights, Nov 2007, Pages: 143 Pharmaceutical Pricing and Reimbursement: Strategies for Market Access Across the US, Europe, Japan and Other Key Geographies The global pharmaceutical pricing and reimbursement environment is The Pricing and Reimbursement Environment for Metabolic Disease Therapies   Decision Resources, Inc., March 2011, Pages: 70 Insurance Coverage - Pharmaceutical Pricing and Reimbursement - Cost Containment - Diabetes - Dyslipidemia - Osteoporosis - Gout Japan - General Environment - Health Insurance - Pharmaceutical Pharmaceutical Pricing, Reimbursement and Market Access News in the First Quarter of 2010   Decision Resources, Inc., May 2010, Pages: 37 Pharmaceutical Pricing, Reimbursement and Market Access News in the First Quarter of 2010 The first quarter of 2010 was one of the most eventful in recent years with regard to pharmaceutical market Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs   GBI Research, May 2012, Pages: 66 Developments 7.5 Contact Us 7.6 Disclaimer 1.1 List of Tables Table 1: Pricing and Reimbursement in Europe, Supply-Side Pharmaceutical Regulations Table 2: Pricing and Reimbursement in Europe, Demand-Side Pricing and Reimbursement of Targeted Cancer Therapies   Decision Resources, Inc., Dec 2009, Pages: 58 Drugs Not Yet Approved in Japan Reimbursement of Targeted Cancer Therapies Outlook and Implications for the Pharmaceutical Industry Tables 1. Ex-Manufacturer Prices of Select Targeted Cancer New Approaches to Gaining Market Access for Pharmaceuticals: Pricing & Reimbursement, Policy Development, and the Role of HTAs   Business Insights, Oct 2010, Pages: 110 opportunities Chapter 1 The pharmaceutical P&R landscape Summary Introduction Pricing and reimbursement in the US Coverage decisions Pricing and reimbursement in Japan Pricing and reimbursement in France Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network